LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects With Dim Light Vision Disturbances

American Journal of Ophthalmology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles